Q2 FY25 saw 20% sequential revenue growth and 42% EBITDA growth, with EPS rising to Rs 3.00. Capacity expanded to 2200 MTPA, and new product launches and regulatory approvals support a positive outlook.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.